Without NLRX1 present, the energy sensor AMPKα is continuously activated in the heart, thereby preventing mTOR and RISK pathway activation during early reperfusion of the ischemic hearts, contributing to the increased sensitivity of the heart to ischemia–reperfusion injury. This evidence concerns the gene NLRX1 and ischemia.